Another link from 2020 regarding Pfizer and China footprint. China is a big opportunity for BP. I’m thinking AMRN and Dr Denner are keenly aware of this. I have to believe Pfizer is actively trying to obtain Vascepa and it’s just a matter of time and a reasonable BO number. If so, it might explain why AMRN didn’t mention the HLS/Pfizer partnership deal when it happened. Enter Dr Denner to get it done!! It could be wishful thinking but I think there’s meat on this bone. I could be wrong.
Market Data 
Markets 
AI
